Search Results 7461-7470 of 34213 for oral

  1. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) Or Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Encephalitis (Cielo) - Mayo Clinic

    * Treatment with oral cyclophosphamide within 1 year prior to baseline Treatment with any investigational drug (including bortezomib) within 24 weeks prior ...

  2. CNS Tumors With Latent Residual Disease To Guide Individualized Therapies - Mayo Clinic

    ... oral medication NOTE: This includes but not limited to, refractory vomiting, gastric resection/bypass, or duodenal/jejunal resection. Patients with known ...

  3. Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma - Mayo Clinic

    ... oral cavity, or nasal mucosa. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 11/20/2024. Questions regarding ...

  4. Clinical Trials - Tesevatinib in Subjects With ADPKD

    Participation eligibility · intrauterine device plus 1 barrier method; · on stable doses of hormonal contraception for at least 3 months (eg, oral, injectable, ...

  5. Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery - Mayo Clinic

    ... oral polio, Bacillus Calmette-Guérin (BCG), yellow fever, varicella and typhoid (TY)21a typhoid vaccines; Current severe hepatic impairment; Note: A detailed ...

  6. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  7. Tonsil cancer - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery ... Oral and throat cancer, Adenocarcinoma, Tongue base cancer, Oropharyngeal cancer.

  8. Publications - Victoria E. Clark, M.D., Ph.D. - Mayo Clinic

    J Oral Maxillofac Surg. 2023 Aug; 81 (8):1021-1024 Epub 2023 May 09. View PubMed; Banani SF, Afeyan LK, Hawken SW, Henninger JE, Dall'Agnese A, Clark VE ...

  9. Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy - Mayo Clinic

    No chronic (duration > 30 days) daily use of oral steroids. Inhaled or topical steroids are allowed. No known allergy to aspirin. No prior invasive ...

  10. Barrier methods of birth control such as condoms and dental dams for oral sex help lower the risk of getting most STIs. If you're sexually active, you can ...